Evidence map›Paper›PMID 32351633›Full record

ArticleDisease markers2020

An Analysis of Five

Renata Suchanek-Raif, Paweł Raif, Małgorzata Kowalczyk, Monika Paul-Samojedny, Aleksandra Zielińska, Krzysztof Kucia, Wojciech Merk, Jan Kowalski

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Renata Suchanek-RaifSchool of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.ORCID https://orcid.org/0000-0002-6836-6127
Paweł RaifDepartment of Biosensors and Biomedical Signals Processing, Silesian University of Technology, Faculty of Biomedical Engineering, Roosevelta 40 Street, Zabrze, Poland.
Małgorzata KowalczykSchool of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.
Monika Paul-SamojednySchool of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.
Aleksandra ZielińskaSchool of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.
Krzysztof KuciaSchool of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Wojciech MerkSchool of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Jan KowalskiSchool of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.
Medical University of Silesia · PLSilesian University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe BDNF dysfunction in the schizophrenia has been soundly documented. The

methodsCase-control study (401 patients and 657 healthy controls) was used to examine a predisposition for schizophrenia. The tests for psychopathology, suicide attempts, and family history of schizophrenia were conducted only in patient group. The severity of the schizophrenia was measured using the five-factor model of the PANSS. In addition, the haplotype analysis for both the separate for SNPs of

resultsOur case-control study revealed that the genetic variants of rs10868235 (T/T polymorphic genotype) and rs1387923 (G/G polymorphic genotype) of the

Indexed as

Polymorphism, Single NucleotideAdolescentAdultBrain-Derived Neurotrophic FactorFemaleHaplotypesHumansMaleMembrane GlycoproteinsReceptor, trkBSchizophreniaBDNF protein, humanBrain-Derived Neurotrophic FactorMembrane GlycoproteinsReceptor, trkBtropomyosin-related kinase-B, human

Identifiers

PMID32351633
PMCPMC7174942
OpenAlexW3017057556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.